Respiratory Infections

Antibiotics and chest x-rays are routinely used to diagnose and treat pediatric CAP, despite guidelines advising the contrary.

At least 8 cases of Legionnaires’ disease have been confirmed in an outbreak within an Ohio hospital that just opened on April 28, 2019

In addition to cUTI and cIAI, ceftolozane/tazobactam (Zerbaxa) is now approved to treat hospital-acquired/ventilator-associated bacterial pneumonia.

According to the New Jersey Department of Health, there have been 22 confirmed cases of Legionnaires’ disease in individuals who reside in or visited Union County.

Long-term care facilities could reduce hospitalizations for pneumonia and influenza by hiring more registered nurses and licensed independent practitioners, increasing staffing hours, and employing higher quality care practices.

Early research found that e-cigarette use affects the immune system response to the flu virus and the effects are different for female and male users.

In an unexpected discovery, a NIAID-funded study team has found that a human antibody can target a part of the hemagglutinin protein that the influenza virus uses to enter and infect cells.

Oral ibrexafungerp demonstrates a favorable therapeutic response in patients with difficult-to-treat Candida infections, including those caused by non-albicans Candida species.

After receiving treatment with ibrexafungerp, a patient with esophageal candidiasis gradually improved and by day 54 he was completely asymptomatic.

An antiviral drug that could offer months of protection against the flu may be on the horizon and ready to fill in some of the gaps of the seasonal flu vaccine.

The American Academy of Pediatrics is giving its recommendation to the nasal spray form of the influenza vaccine for the 2019-2020 flu season, meaning parents will have 2 choices when getting their children vaccinated this fall.

Following a 1-month delay, WHO experts have issued a recommendation for a new influenza A(H3N2) component for next flu season.

On the anniversary of the discovery of the bacterium that causes tuberculosis, world health leaders are highlighting an epidemic that kills nearly 4500 people each day across the world.

Solving a years-old mystery, investigators have discovered that MHC-II molecules can provide a gateway for bat influenza to infect human cells.

Infectious diseases were responsible for 6% of unexpected deaths over a 2-year period in Ontario, highlighting the importance of prevention strategies.

Although 30% of adults with XDR TB are successfully cured or complete treatment, a new study has found that children have far more favorable outcomes and lower mortality rates.

Although influenza A H1N1 continues to dominate the current flu season in the US, H3N2 viruses are on the rise in some parts of the country.

Spero Therapeutics announced that SPR720, an oral agent being developed for the treatment of lung infections caused by NTM, has received QIDP designation from the FDA.

Mycobacterium avium isolates were detected in household water in 81.1% of households sampled in a new study, suggesting a link to Mycobacterium avium complex lung disease.

A study reports that a respiratory virus infection diagnosis was not linked with a decrease in antibiotic exposure and use of respiratory viral panels did not affect clinical outcomes.

Antibiotic prescription following ventilation in children with RSV-LRTI was associated with a 1.21-day shorter duration of ventilation and a 2.07-day shorter length of hospital stay.

The FDA has approved room temperature stable, premixed vancomycin injections, which will be available in ready-to-use bags.

A computer simulation model developed by NYU investigators uses math to forecast influenza activity.

Lessons from the frontlines of post-hurricane public health response

Japanese researchers find a concerning resistance to a new antiviral flu medication.